The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
DSpace/Manakin Repository
The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Filippi, Luca; Braat, Arthur J; Schillaci, Orazio
(2022) European Journal of Nuclear Medicine and Molecular Imaging, volume 49, issue 12, pp. 3977 - 3978
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Antigens, Surface, Carcinoma, Hepatocellular/diagnostic imaging, Glutamate Carboxypeptidase II, Humans, Liver Neoplasms/diagnostic imaging, Male, Precision Medicine, Prostate-Specific Antigen, Prostate/pathology, Prostatic Neoplasms/diagnostic imaging, Radiology Nuclear Medicine and imaging, Comment, Letter
DOI:
https://doi.org/10.1007/s00259-022-05928-0
ISSN: 1619-7070
Publisher: Springer Verlag
(Peer reviewed)